MC2 Center appears in the news
Publication Highlight: Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer
Guest Author: Ashenafi Bulle, Ph.D., Washington University School of Medicine in St. Louis In this work, we shed light on the significance of drug combinations [...]